Sanofi, Oncodesign in kinase inhibitor deal

Oncodesign S.A. (Dijon, France) and Sanofi (Euronext:SAN; NYSE:SNY) partnered to use Oncodesign's Nanocyclix medicinal chemistry technology to discover and develop inhibitors against undisclosed kinas...